LITMIR.BIZ

Скачать книгу

Meeting Copenhagen, Denmark, July 3–5, 2014, Published in: Vet Surg 43(5):E125.

      155 Hartmann, K., M.J. Day, E. Thiry, et al. 2015. Feline injection‐site sarcoma: ABCD guidelines on prevention and management. J Feline Med Surg 17(7):606–613.

      156 Headley, S.A., A.C. Faria Dos Reis, and A.P. Frederico. 2011. Cutaneous myxosarcoma with pulmonary metastases in a dog. J Comp Pathol 145(1):31–34.

      157 Heller, D., M.E. Stebbins, T. Reynolds, et al. 2005. A retrospective study of 87 cases of canine soft tissue sarcoma, 1986–2001. Int J Appl Res Vet Med 3:81–87.

      158 Hendrick, M.J. and M.H. Goldschmidt. 1991. Do injection site reactions induce fibrosarcomas in cats? J Am Vet Med Assoc 199(8):968.

      159 Henney, L.H. and M.M. Pavletic. 1988. Axial pattern flap based on the superficial brachial artery in the dog. Vet Surg 17(6):311–317.

      160 Hergt, F., W. von Bomhard, M.S. Kent, et al. 2016. Use of a 2‐tier histologic grading system for canine cutaneous mast cell tumors on cytology specimens. Vet Clin Pathol 45(3):477–483.

      161 Hershey, A.E., K.U. Sorenmo, M.J. Hendrick, et al. 2000. Prognosis for presumed feline vaccine‐associated sarcoma after excision: 61 cases (1986–1996). J Am Vet Med Assoc 216(1):58–61.

      162 Hill, J., J. Lawrence, C. Saba, et al. 2014. In vitro efficacy of doxorubicin and etoposide against a feline injection site sarcoma cell line. Res Vet Sci 97(2):348–356.

      163 Hobert, M.K., C. Brauer, P. Dziallas, et al. 2013 Infiltrative lipoma compressing the spinal cord in 2 large‐breed dogs. Can Vet J 54(1):74–78.

      164 Horta, R.D.S., A. Giuliano, G.E. Lavalle, et al. 2018. Clinical, histological, immunohistochemical and genetic factors associated with measurable response of high‐risk canine mast cell tumours to tyrosine kinase inhibitors. Oncol Lett 15:129–136.

      165 Hosoya, K., W.C. Kisseberth, F.J. Alvarez, et al. 2009. Adjuvant CCNU (lomustine) and prednisone chemotherapy for dogs with incompletely excised grade 2 mast cell tumors. J Am Anim Hosp Assoc 45(1):14–18.

      166 Hudson‐Peacock, M.J. and C.M. Lawrence. 1995. Comparison of wound closure by means of dog ear repair and elliptical excision. J Am Acad Dermatol 32(4):627–630.

      167 Hughes, J.R., B. Szladovits, and R. Drees. 2019. Abdominal CT evaluation of the liver and spleen for staging mast cell tumors in dogs yields nonspecific results. Vet Radiol Ultrasound 60(3):306–315.

      168 Hume, C.T., M. Kiupel, L. Rigatti, et al. 2011. Outcomes of dogs with grade 3 mast cell tumors: 43 cases (1997–2007). J Am Anim Hosp Assoc 47(1):37–44.

      169 Hunt, G.B., J. Wong, and S. Kuan. 2011. Liposuction for removal of lipomas in 20 dogs. J Small Anim Pract 52(8):419–425.

      170 Isotani, M., N. Ishida, M. Tominaga, et al. 2008. Effect of tyrosine kinase inhibition by imatinib mesylate on mast cell tumors in dogs. J Vet Intern Med 22(4):985–988.

      171 Jaber, O., M. Vischio, A. Faga, et al. 2015. The three‐bite technique: A novel method of dog ear correction. Arch Plast Surg 42(2):223–225.

      172 Jackson, D.E., L.M. Berent, L.A. Cohn, et al. 2011. Locally invasive lymphangiosarcoma in a young domestic shorthair. J Feline Med Surg 13(10):796–799.

      173 Jaffe, M.H., G. Hosgood, S.C. Kerwin, et al. 2000. Deionised water as an adjunct to surgery for the treatment of canine cutaneous mast cell tumors. J Small Anim Pract 41(1):7–11.

      174 Johannes, C.M., C.J. Henry, S.E. Turnquist, et al. 2007. Hemangiosarcoma in cats: 53 cases (1992–2002). J Am Vet Med Assoc 231(12):1851–1856.

      175 Johnson, T.O., F.Y. Schulman, T.P. Lipscomb, et al. 2002. Histopathology and biologic behavior of pleomorphic cutaneous mast cell tumors in fifteen cats. Vet Pathol 39(4):452–457.

      176 Jourdier, T.M., C. Moste, M.C. Bonnet, et al. 2003. Local immunotherapy of spontaneous feline fibrosarcomas using recombinant poxviruses expressing interleukin 2 (IL2). Gene Ther 10(26):2126–2132.

      177 Kaldrymidou, H., L. Leontides, A.F. Koutinas, et al. 2002. Prevalence, distribution and factors associated with the presence and the potential for malignancy of cutaneous neoplasms in 174 dogs admitted to a clinic in northern Greece. J Vet Med A Physiol Pathol Clin Med 49(2):87–91.

      178 Kamstock, D., R. Elmslie, D. Thamm, et al. 2007. Evaluation of a xenogeneic VEGF vaccine in dogs with soft tissue sarcoma. Cancer Immunol Immunother 56(8):1299–1309.

      179 Kantor, J. 2015. The dog‐ear tacking suture technique. J Am Acad Dermatol 73(1):e25–e26.

      180 Kapatkin, A.S., H.S. Mullen, D.T. Matthiesen, et al. 1992. Leiomyosarcoma in dogs: 44 cases (1983–1988). J Am Vet Med Assoc 201(7):1077–1079.

      181 Karbe, G.T., E. Davis, J.J. Runge, et al. 2021. Evaluation of scar revision after inadequate primary excision of cutaneous mast cell tumors in 85 dogs (2000–2013). Vet Surg. 50(4):807–815.

      182 Kass P.H., W.G. Barnes Jr., W.L. Spangler, et al. 1993. Epidemiological evidence for a causal relation between vaccination and fibrosarcoma tumorigenesis in cats. J Am Vet Med Assoc 203:396–405.

      183 Kass, P.H., W.L. Spangler, M.J. Hendrick, et al. 2003. Multicenter case control study of risk factors associated with development of vaccine‐associated sarcomas in cats. J Am Vet Med Assoc 223(9):1283–1292.

      184 Katayama R., M.K. Huelsmayer, A.K. Marr, et al. 2004. Imatinib mesylate inhibits platelet‐derived growth factor activity and increases chemosensitivity in feline vaccine‐associated sarcoma. Cancer Chemother Pharmacol 54: 25–33.

      185 Kim, H.J., H.S. Chang, C.B. Choi, et al. 2005. Infiltrative lipoma in cervical bones in a dog. J Vet Med Sci 67(10):1043–1046.

      186 Kim, D.Y., D.Y. Cho, D.Y. Kim, et al. 2003. Malignant peripheral nerve sheath tumor with divergent mesenchymal differentiations in a dog. J Vet Diagn Invest 15(2):174–178.

      187 Kirby, P.M., J.M. Miller, J.M. Goggin. 2014. What is your diagnosis? Grade 2 myxosarcoma of the subcutis and bone. J Am Vet Med Assoc 245(11):1221–1223.

      188 Kirpensteijn, J. and G. Ter Haar. 2013. Reconstructive Surgery and Wound Management of the Dog and Cat. Boca Raton: CRC Press.

      189 Kiupel, M., J.D. Webster, J.B. Kaneene, et al. 2004. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors. Vet Pathol 41(4):371–377.

      190 Kiupel, M., J.D. Webster, R.A. Miller, et al. 2005. Impact of tumor depth, tumor location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumors. J Vet Med A Physiol Pathol Clin Med 52(6):280–286.

      191 Kiupel, M., J.D. Webster, K.L. Bailey, et al. 2011. Proposal of a 2‐tier histologic grading system for canine cutaneous mast cell tumors to more accurately predict biological behavior. Vet Pathol 48(1):147–155.

      192 Kliczkowska, K., U. Jankowska, D. Jagielski, et al. Epidemiological and morphological analysis of feline injection site sarcomas. 2015. Pol J Vet Sci 18(2):313–322.

      193 Kobayashi, T, M.L. Hauck, R. Dodge, et al. 2002. Preoperative radiotherapy for vaccine associated sarcoma in 92 cats. Vet Radiol Ultrasound 43(5):473–479.

      194 Kolm, U.S., M. Kleiter, A. Kosztolich, et al. 2002. Benign intrapericardial lipoma in a dog. J Vet Cardiol 4(1):25–29.

      195 Kok, M.K., J.K. Chambers, M. Tsuboi, et al. 2019. Retrospective study of canine cutaneous tumors in Japan, 2008–2017. J Vet Med Sci 81(8):1133–1143.

      196 Kotilingam, D., D.C. Lev, A.J. Lazar, et al. 2006. Staging soft tissue sarcoma: Evolution and change. CA Cancer J Clin 56(5):282–291.

      197 Kraus, K.A., C.A. Clifford, G.J. Davis, et al. 2015. Outcome and prognostic indicators in cats undergoing splenectomy for splenic mast cell tumors. J Am Anim Hosp Assoc 51(4):231–238.

      198 Krick, E.L., A.P. Billings, F.S. Shofer, et al. 2009. Cytological lymph node evaluation in dogs with mast cell tumors: Association with grade and survival. Vet Com Oncol 7(2):130–138.

      199 Kristal, O., K.M. Rassnick, J.M. Gliatto, et al. 2004.

Скачать книгу